Bruno Del Prato
U.O.S.C. Pneumologia Interventistica A.O.R.N.A. Cardarelli, Napoli, Italy
Alfonso Maria Altieri
U.O.C. Broncopneumologia e Tisiologia, A.O. S. Camillo-Forlanini, Roma, Italy
Biagio Carlucci
U.O.C. Pneumologia-UTIR, Ospedale Madonna delle Grazie, Matera, Italy
Pier Anselmo Mori
U.O.C. Pneumologia ed Endoscopia Toracica, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Roberto Parrella
U.O.C. Malattie Infettive ad indirizzo respiratorio, A.O.R.N. dei Colli - Cotugno Hospital – Naples, Italy
Anna Stainer
Dipartimento Cardio-Toraco-Vascolare, University of Milan Bicocca, Respiratory Unit, San Gerardo
Hospital, ASST di Monza, Monza, Italy
Federica De Giacomi
Dipartimento Cardio-Toraco-Vascolare, University of Milan Bicocca, Respiratory Unit, San Gerardo
Hospital, ASST di Monza, Monza, Italy
Alberto Pesci
Dipartimento Cardio-Toraco-Vascolare, University of Milan Bicocca, Respiratory Unit, San Gerardo
Hospital, ASST di Monza, Monza, Italy
Paola Faverio
Dipartimento Cardio-Toraco-Vascolare, University of Milan Bicocca, Respiratory Unit, San Gerardo
Hospital, ASST di Monza, Monza, Italy
on behalf of Gruppo di Studio AIPO
Abstract
The incidence of non-tuberculous mycobacteria (NTM) infection is increasing in Europe. However, a picture of Italian epidemiology and clinical practice is missing. We performed a national Italian survey involving 42 respiratory medicine departments. The NTM species more frequently isolated were Mycobacterium avium complex, followed by M. xenopi and M. kansasii. Patients with NTM were more frequently female (57%), and over 60 years of age, with bronchiectasis and COPD as main comorbidities. Bronchoscopic samples were widely used in the diagnostic phase. Of all patients with NTM, 73% met the criteria for NTM pulmonary disease. Despite strong adherence to the guidelines, physicians found significant difficulties related to pharmacological adverse events, patients’ compliance and poor outcomes.
Abstract